Many patients stop, restart statin drug therapy

04/3/2013 | Medscape (free registration)

More than half of patients on a statin who experienced an adverse event stopped taking the drug, but more than 50% also restarted the drug or tried a new statin later on, according to researchers at Brigham and Women's Hospital in Boston. The study in the Annals of Internal Medicine showed 66% of patients who stopped taking a statin for reasons besides an adverse event had another statin prescription over the following year, and 98% of those who restarted statin therapy were still compliant a year later.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA